Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD
Related Posts
Lian K, Sun PY, Lian K, Markovic D, Ibish A, Faigle R, Gottesman RF, Towfighi A. Race/Ethnic Differences in In-Hospital Mortality after Acute Ischemic Stroke.[...]
Sahashi Y, Vukadinovic M, Amrollahi F, Trivedi H, Rhee J, Chen J, Cheng S, Ouyang D, Kwan AC. Opportunistic Screening of Chronic Liver Disease with[...]
Al-Jarshawi M, Martin GP, Cole A, Menezes MN, Cheng RK, Lopez-Mattei J, Yang EH, Mamas MA. Prognostic significance of abdominal aortic calcification scores on dual-energy[...]